Needham & Company analyst Alan Carr, Ph.D. reiterated a Buy and raised his price target on Gilead Sciences (NASDAQ: GILD) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE